CLIPAD

Use of Intravascular Lithotripsy for Severe Calcification in Endovascular Aortoiliac Reconstruction

Purpose: Arterial calcification is common in peripheral arterial disease, often resulting in suboptimal clinical outcomes after angioplasty and stent placement. The use of intravascular l...

Sanjiv S. Virdee , MD;

;

01/21/2022

Endovascular Approach in Treatment of Hypogastric Artery Pseudoaneurysm, A Rare Condition After Aorto-biiliac Bypass

Purpose: Hypogastric artery pseudoaneurysm (HAP) has a rare incidence, and it is usually asymptomatic. It can present with neurologic symptoms such as paresthesia, sciatica, weakness of t...

01/20/2022

Meeting Exclusive

The American Diabetes Association’s Role in Preventing Amputations

01/20/2022

Pauravi (Po) Raval , DPM, MS;

During a Town Hall session at ISET 2022 focused on racial disparities in amputations, Stephanie Silverman, board member of the American Diabetes Association (ADA), spoke to attendees about the role that the ADA has taken in helping prevent...

During a Town Hall session at...

01/20/2022

Vascular Disease Management

6-Month Results From the PATHFINDER Registry Evaluating the Safety and Efficacy of the Auryon Laser

Purpose: The purpose is to report the safety and efficacy of the Auryon Laser Atherectomy System (AngioDynamics) in a postmarket study treating infrainguinal lesions and occlusions. ...

John H. Rundback , MD, FAHA, FSIR;

01/20/2022

Caput Medusa: A Critical Limb Ischemia Conundrum

Purpose: Peripheral artery disease is a growing pandemic, with a prevalence higher than ischemic heart disease and cancer combined. Critical limb ischemia, the deadliest form of the disea...

Mark Domyahn ;

Ryan Gillespie ;

Ryan Gerecht , MD, FACEP;

Shadi Al Halabi , MD, MPH;

Ryan Haarer ;

01/20/2022

Accuracy Evaluation of Noninvasive Technology to Analyze Lower Extremity Arteries and Blood Flow

Purpose: Peripheral artery disease (PAD) continues to be underdiagnosed and thereby untreated early in its progression, leading to unnecessary health care costs and, more crucially, unnec...

01/20/2022

Meeting Exclusive

Long-term Outcomes for Resorbable DES for BTK Applications and LIFE-BTK Trial Update

01/18/2022

Ramon L. Varcoe , MBBS, MS, PhD;

Debra L. Beck , MSc;

At ISET 2022, Dr. Ramon L. Varcoe presented the 5-year findings for the Absorb device and an update on resorbable drug-eluting scaffolds for BTK applications.

At ISET 2022, Dr. Ramon L....

01/18/2022

Vascular Disease Management

Meeting Exclusive

Three-Year Survival in CLTI Patients with FFR-Guided Revascularization of Silent Coronary Ischemia

01/18/2022

Debra L. Beck , MSc;

Christopher K. Zarins , MD;

Christopher K. Zarins, MD, presented the 3-year findings from his recently published trial on the benefits of coronary computed-tomography derived FFRct in the evaluation of CLTI patients.

Christopher K. Zarins, MD,...

01/18/2022

Vascular Disease Management

Meeting Exclusive

IN.PACT Global Study: 5-Year Diabetic and Gender Subgroup Outcomes

01/17/2022

Marianne Brodmann , MD;

Debra L. Beck , MSc;

At ISET 2022, Dr. Marianne Brodmann discussed outcomes from the IN.PACT Global Study stratified according to gender and diabetes status.

At ISET 2022, Dr. Marianne...

01/17/2022

Vascular Disease Management